An initiative to strengthen the overseas operating platform centered on India by making 3 Indian companies consolidated subsidiaries and integrating the process from raw material procurement through the manufacture and sale of bovine bone gelatin. This also involves restructuring the overseas footprint, including the suspension of production at the US facility and the liquidation of the local entity.